The current status of heroin prescription treatment for heroin dependence
Author:
- 7 September 2005
- journal article
- Published by Informa Healthcare in Expert Opinion on Drug Safety
- Vol. 4 (5) , 815-819
Abstract
Heroin prescription (HP) to treat severe heroin dependence has been available to few patients in the UK for several decades with limited, but generally favourable, evaluation. In the last decade, large trials have been reported from two countries, are presently underway in three other countries and under consideration in several other countries. The standard pharmacological treatments for heroin dependence, methadone and buprenorphine, attract and retain many more drug users than other pharmacological or nonpharmacological treatments and are strongly supported by evidence of efficacy, effectiveness, safety and cost effectiveness. On present evidence, HP is feasible and safe with limited, but increasing, evidence of efficacy and effectiveness. Although HP is more expensive than methadone, there is some evidence of cost effectiveness. HP is, at present, only considered a therapeutic option for a small minority of treatment refractory, severely heroin-dependent persons in developed countries with comprehensive treatment systems.Keywords
This publication has 22 references indexed in Scilit:
- Matching of treatment‐resistant heroin‐dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trialsAddiction, 2004
- Prescription of heroin to treatment resistant heroin addictsBMJ, 2004
- Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trialsBMJ, 2003
- Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up studyThe Lancet, 2001
- DiscussionJournal of Substance Abuse Treatment, 1999
- Effects of Heroin Prescription on Police Contacts among Drug-AddictsEuropean Journal on Criminal Policy and Research, 1998
- Global mortality, disability, and the contribution of risk factors: Global Burden of Disease StudyThe Lancet, 1997
- Prescribing drug of choice to illicit heroin users: The experience of a U.K. community drug teamJournal of Substance Abuse Treatment, 1996
- Drug Prohibition in the United States: Costs, Consequences, and AlternativesScience, 1989
- Evaluation of Heroin Maintenance in Controlled TrialArchives of General Psychiatry, 1980